Haemonetics Corporation (HAE)

Net profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Net income (ttm)	US$ in thousands	117,558	126,574	128,277	136,566	115,401	95,759	86,047	67,706	43,375	22,593	31,243	64,488	79,469	108,134	106,147	95,532	76,526	79,737	41,363	22,603
Revenue (ttm)	US$ in thousands	2,596,175	2,424,725	2,393,776	2,373,078	2,323,237	1,114,154	1,068,622	1,011,034	987,485	954,649	935,251	904,840	862,112	882,733	901,332	944,412	989,857	1,000,660	989,046	978,061
Net profit margin		4.53%	5.22%	5.36%	5.75%	4.97%	8.59%	8.05%	6.70%	4.39%	2.37%	3.34%	7.13%	9.22%	12.25%	11.78%	10.12%	7.73%	7.97%	4.18%	2.31%

March 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $117,558K ÷ $2,596,175K
= 4.53%

The net profit margin of Haemonetics Corporation has shown fluctuations over the past 20 quarters. It ranged from a low of 2.31% in the third quarter of 2019 to a high of 12.25% in the fourth quarter of 2020. In the most recent quarter, ending March 31, 2024, the net profit margin stood at 4.53%.

The trend in the net profit margin indicates some level of volatility, possibly influenced by various internal and external factors impacting the company's profitability. It is essential to further investigate the financial performance and operational efficiency of Haemonetics Corporation to gain insights into the factors driving the fluctuations in its net profit margin.